I think you are right TDA - The AGC JV has opened a lot of doors to top pharmas in Japan, as AGC has immense credibility and contacts in Japan in particular. Who the JV got down to terms sheets is known only to them at this stage, but I thinks RGS would be happy having multiple interested parties having a good look at Progenza.